(Reuters) – The U.S. Food and Drug Administration has approved Gamida Cell Ltd’s blood cancer therapy, Omisirge, the health regulator said on Monday.
(Reporting by Pratik Jain in Bengaluru)
US FDA approves Gamida’s blood cancer therapy
Apr 17, 2023 | 1:10 PM
